Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Myriad Genetics (MYGN) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Steve Beuchaw saying the core HCT business is showing more durability, with volumes returning to growth and price declines slowing, while the acquisitions of Assurex and Counsyl are diversifying the company into higher growth and improving average selling price testing markets. 2. HSBC (HSBC) upgraded to Overweight from Neutral at JPMorgan with analyst Katherine Lei saying despite stable asset quality and an improving net interest margin outlook, HSBC's share price corrected 14% from the peak in January. 3. Conn's (CONN) upgraded to Buy from Hold at Stifel with analyst John Baugh saying he left a recent meeting with management feeling confident that the recent indications of improvement in the credit segment should continue. 4. TripAdvisor (TRIP) upgraded to Overweight from Equal Weight at Barclays with analyst Deepak Mathivanan saying the company's fundamentals "are starting to turn around." 5. Imperial Oil (IMO) upgraded to Equal Weight from Underweight at Barclays. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.